Advertisement

Mindray Medical completes its acquisition of Wuhan Dragonbio Surgical Implants' orthopedics division for $35.5 million.

Mindray Medical logo

Mindray (NYSE:MR) announced that it completed the $35.5 million acquisition of the Wuhan, China-based Wuhan Dragonbio Surgical Implants' orthopedics business.

Mindray currently manufactures and deals in patient monitoring and life support, in-vitro diagnostic and medical imaging systems worldwide, but with the acquisition of Dragonbio's orthopedics business, the company will be able to spread its presence in China as well as explore the orthopedics industry.

Advertisement
Advertisement